Press release
October 26, 2026
Biohaven Oral Presentation at ASN Kidney Week 2026 Spotlights BHV-1420, a Novel TRAP Degrader Designed to Selectively Remove the Autoantibodies that Drive Membranous Nephropathy
Biohaven Ltd. (BHVN)
We couldn't retrieve the full text for this release. Read it on the company's site.